Illusory generalizability of clinical prediction models.

Journal: Science (New York, N.Y.)
Published Date:

Abstract

It is widely hoped that statistical models can improve decision-making related to medical treatments. Because of the cost and scarcity of medical outcomes data, this hope is typically based on investigators observing a model's success in one or two datasets or clinical contexts. We scrutinized this optimism by examining how well a machine learning model performed across several independent clinical trials of antipsychotic medication for schizophrenia. Models predicted patient outcomes with high accuracy within the trial in which the model was developed but performed no better than chance when applied out-of-sample. Pooling data across trials to predict outcomes in the trial left out did not improve predictions. These results suggest that models predicting treatment outcomes in schizophrenia are highly context-dependent and may have limited generalizability.

Authors

  • Adam M Chekroud
    Department of Psychology, Yale University, New Haven, CT.
  • Matt Hawrilenko
    Spring Health, New York City, NY 10010, USA.
  • Hieronimus Loho
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA.
  • Julia Bondar
    Spring Health, New York City, NY 10010, USA.
  • Ralitza Gueorguieva
    Department of Biostatistics, Yale University, New Haven, CT, USA.
  • Alkomiet Hasan
    Department of Psychiatry and Psychotherapy, Klinikum der Universität München, Ludwig-Maximilians-Universität, Munich.
  • Joseph Kambeitz
    Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University, Munich, Germany;
  • Philip R Corlett
    Department of Psychiatry, Yale University, New Haven, CT, USA. philip.corlett@yale.edu.
  • Nikolaos Koutsouleris
    Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, United Kingdom.
  • Harlan M Krumholz
    Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT, USA.
  • John H Krystal
    Department of Psychiatry, Yale University, New Haven, Connecticut.
  • Martin Paulus
    VA San Diego Healthcare System and Department of Psychiatry, University of California San Diego, La Jolla, California, USA.